Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Computerized assessment of memory performance in dementia.

F I Perez, N A Hruska, R L Stell

    The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
    |August 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Therapeutic attitudes towards multiple sclerosis in Central America and the Caribbean facing the SARS-CoV-2 pandemia].

    Neurologia·2020
    Same author

    Multiple sclerosis as a universal disease and the challenges to immigrants in high prevalence countries.

    European journal of neurology·2018
    Same author

    A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias.

    The New England journal of medicine·2013
    Same author

    Phase I/IIa trial of the mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) administered orally in patients with refractory or advanced malignancies and sarcoma.

    Annals of oncology : official journal of the European Society for Medical Oncology·2012
    Same author

    Evaluation of a rapamycin-regulated serotype 2 adeno-associated viral vector in macaque parotid glands.

    Oral diseases·2010
    Same author

    Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel.

    Annals of oncology : official journal of the European Society for Medical Oncology·2009

    This study introduces a computerized system to assess memory deficits in dementia patients using visual and verbal tasks. The system accurately identifies subtle memory changes, aiding in neurological impairment assessment and early detection of mental changes in the elderly.

    Area of Science:

    • Neuroscience
    • Cognitive Psychology
    • Medical Technology

    Background:

    • Dementia is characterized by progressive memory deficits.
    • Accurate assessment of memory function is crucial for diagnosis and management.
    • Existing methods may not capture subtle changes in memory performance.

    Purpose of the Study:

    • To develop and evaluate a computerized system for titrating individual memory performance in demented patients.
    • To assess visual and verbal memory using delayed matching to sample tasks.
    • To explore the system's utility as a screening tool for mental changes in the elderly.

    Main Methods:

    • A computerized system was applied to two delayed matching to sample tasks: ABA1 (visual shapes) and ABA2 (verbal trigrams).
    • A Human Test System panel with a 2x2 matrix display was utilized.

    Related Experiment Videos

  • Task parameters, data acquisition, and retrieval were computerized, with variable delay intervals based on patient performance.

    • Main Results:

    • Individual titration levels correlated with the severity of neurological impairment.
    • The computerized assessment effectively identified subtle changes in memory performance.
    • The system demonstrated potential for screening mental changes in the elderly.

    Conclusions:

    • Computerized assessment offers a sensitive method for evaluating memory deficits in dementia.
    • The developed system can provide objective measures of memory function.
    • This technology has implications for early detection and monitoring of cognitive decline.